Overall | Head US first (or sole imaging modality) (n = 39) | CT or MRI first (or sole imaging modality (n = 7) | p | |
---|---|---|---|---|
Birthweight (g) (mean + SD) | 2707 ± 741 | 2738 ± 791 | 2540 ± 405 | 0.54 |
Gestational age (weeks) (mean, SD) | 38.0 ± 2.79 | 38.0 ± 0.98 | 38.2 ± 3.02 | 0.85 |
Presence of clinically apparent symptomsa | 24 (54%) | 20 (57.1%) | 4 (51.2%) | 0.78 |
Microcephaly | 5 (11%) | 4 (12%) | 1 (14%) | 0.89 |
Laboratory abnormalitiesb | 22 (48%) | 18 (46.1%) | 4 (57.1%) | 0.59 |
Sensineural hearing lossc | 19 (41.3%) | 13 (33%) | 6 (85.7%) | < 0.01 |
CMV tested on clinical suspicion vs. screening program | 28 (61%_) | 24 (57.1%) | 4 (61.5%) | 0.83 |